Screenshot of Purdue Pharma’s website. Courtesy photo.
OxyContin maker Purdue Pharma and lawyers representing local governments both said they’re interested in continuing negotiations to settle lawsuits over the toll of the opioid crisis a day after two state attorneys general told colleagues that their talks with the company were at an impasse and that they expected the company to file imminently for bankruptcy.
The statements add another layer of uncertainty to attempts to strike a deal with a company that’s portrayed as a prime villain in the national opioid crisis.
